For the present study, we analyzed a B-CLL population of 30 patients at different disease stage and characterized by different canonical clinical prognostic markers (CD38, IgHV status, chromosomal aberrations and TP53 mutations) (Table 1). Here, TP53 is linked to B-cell chronic lymphocytic leukemia.